Waters Corporation (WAT) appears to be showing a mixture of performance, with episodes of both underperforming and outperforming its competitors. The company's Q1 2024 earnings aligned with EPS projections amidst a sales decline, and it's accelerating development in gene-based therapeutics with the GTxResolve Premier SEC Columns. However, there seem to be struggles tied to its share price pace. Multiple entities, including Manchester Capital Management, Private Advisor Group, and Diversified Trust Co, have reduced their positions in WAT. Yet, stakeholders like Mirae Asset Global Investments and Foguth Wealth Management have increased their stakes. Waters Corporation has been acknowledged by its board being named 2024 Public Company Board of the Year by NACD New England. The company has also made steps towards innovation with the launch of new products like the Rheo-IS accessory and the ACQUITY QDa II Mass Detector. There is a recent effort in sustainability as the company has earned a designation from My Green Lab for the Xevo TQ Absolute System, and it's highlighted ESG progress in its 2022 report. Overall, the company presents a mixed picture in terms of financial performance and innovation.
Waters Corp WAT News Analytics from Tue, 28 Jul 2015 07:00:00 GMT to Sat, 13 Jul 2024 12:02:26 GMT -
Rating 2
- Innovation 5
- Information 8
- Rumor 1
